News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Results from phase 3 CEPHEUS study are out – MSK Department of Medicine
MSK Department of Medicine/X
Feb 12, 2025, 09:31

Results from phase 3 CEPHEUS study are out – MSK Department of Medicine

MSK Department of Medicine shared a post on X about a recent paper by Saad Usmani et al. published in Nature Medicine:

“A phase 3 clinical trial led by Saad Usmani found that a combination of four therapies significantly improved outcomes for people with newly diagnosed multiple myeloma who were not eligible for a transplant. Learn more.”

“Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS study”

Authors: Saad Usmani, Thierry Facon, Vania Hungria, Robin Carson, Sonja Zweegman et al.

Results from phase 3 CEPHEUS study are out - MSK Department of Medicine

More posts featuring MSK Department of Medicine.

cancer CEPHEUS MSK Department of Medicine multiple myeloma OncoDaily Oncology Robin Carson Saad Usmani Sonja Zweegman Thierry Facon Vania Hungria
Special Coverage
OncoDaily Pulse
Feb 12, 2025, 11:30
ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration
Feb 12, 2025, 11:25
Breast Cancer: Symptoms Causes, Stages, Diagnosis and Treatment
Oncolibrary
Feb 12, 2025, 10:41
New Paper Alert: Survival and Treatment Outcomes of Pancreatic Cancer in Armenia: A 12-Year Retrospective Study
Blog
Feb 12, 2025, 10:04
International Cancer Foundation's first Regional Partners Forum
Blog
Feb 12, 2025, 10:03
POHER Scholar alum Martha Kamanga at the Levy Mwanawasa University Teaching Hospital
Insight
Feb 12, 2025, 09:49
Nathan Cherny on the ongoing disparities in access to essential cancer medicines - ESMO
Science
Feb 12, 2025, 09:47
Suman Kumar Vodnala: A novel three-gene "MANAscore" algorithm for lung cancer and melanoma patients
Blog
Feb 12, 2025, 09:40
Yvonne Diaz at the Pistoia Alliance's annual London Conference - Oncogene Cancer Research
Blog
Feb 12, 2025, 09:37
Gertjan Rasschaert: Immunosensitivity cuts across mismatch repair status in colorectal cancer
Science
Feb 12, 2025, 09:32
Evolving field of immunotherapy: pioneering new paths in SCLC by Antonious Ziad Hazim et al.
Insight
Feb 12, 2025, 09:31
Results from phase 3 CEPHEUS study are out - MSK Department of Medicine
Science
Feb 12, 2025, 09:24
High-purity CTC RNA sequencing identifies prognostic prostate cancer phenotypes by Marina Sharifi et al.